Dr. William Pomeroy III, MD
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 19
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 1,601
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
NC license 2019-02438 -
Internal Medicine Physician
VA license 0101244764 - Military Health Care Provider
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Mission Hospital and Asheville Surgery Ce Asheville, NC
- Adventhealth Hendersonville Hendersonville, NC
- Haywood Regional Medical Center Clyde, NC
- Transylvania Regional Hospital, Inc Brevard, NC
- Angel Medical Center Franklin, NC
Medical groups
- Mission Health Community Multispecialty Providers LLC (601 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,601
- Services billed
- 27,699
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Injection, inclisiran, 1 mg | 10,508 | 21 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 635 | 626 |
| Established patient office or other outpatient visit, 30-39 minutes | 550 | 366 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 287 | 259 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 171 | 82 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 114 | 113 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 83 | 82 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 74 | 74 |
| Ultrasound of heart blood flow, valves and chambers | 72 | 71 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 67 | 66 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Asheville, NC | 651 |
| Metoprolol Succinate Other prescribers in Asheville, NC | 543 |
| Atorvastatin Calcium Other prescribers in Asheville, NC | 471 |
| Spironolactone Other prescribers in Asheville, NC | 459 |
| Amlodipine Besylate Other prescribers in Asheville, NC | 413 |
| Rosuvastatin Calcium Other prescribers in Asheville, NC | 398 |
| Carvedilol Other prescribers in Asheville, NC | 373 |
| Metoprolol Tartrate Other prescribers in Asheville, NC | 334 |
| Losartan Potassium Other prescribers in Asheville, NC | 326 |
| Entresto (sacubitril/valsartan) Other prescribers in Asheville, NC | 240 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 33 payments worth $1,264 in total to this clinician.
| Food and Beverage | $1,264 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $64,716 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fi…
Janssen Research & Development, LLC - A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
Amgen Inc. - A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Participants With Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a)
Amgen Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.